Elizabeth D. Strong, NP

Paula Busse is an Allergy and Immunologist practicing medicine in New York,, New York. Dr. Busse is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Hereditary Angioedema, Angioedema, Hives, and Asthma.

Joshua Milner is a leader in the field of discovery and immunopathogenesis of genetic diseases that lead to allergic symptoms. Among the disorders he has described and/or found major mechanistic insight are PLAID—an immune disorder that leads to lifelong cold urticaria, the glycosylation disorder PGM3 deficiency, ERBIN mutation, CARD11 dominant negative mutations, STAT3 gain-of-function, Hereditary Alpha Tryptasemia Syndrome, IL-6 receptor deficiency, and others. Dr. Milner graduated with an SB in biology from the Massachusetts Institute of Technology (MIT) in 1995 and an MD with distinction in immunology from the Albert Einstein College of Medicine. He completed his residency in pediatrics at the Children’s National Medical Center in Washington, DC, and, as the recipient of the Pediatric Scientist Development Program Fellowship, did his fellowship in allergy and immunology at NIAID. He completed a postdoctoral fellowship with Dr. William E. Paul, NIAID, examining issues of mouse T-cell receptor repertoires before beginning as an investigator in the Laboratory of Allergic Diseases in the NIAID, where he was eventually named chief.Dr. Milner's vision is to establish how genetic variation can help inform diagnosis and care of all patients with allergic disease—rare and common, severe and mild. This is achieved by performing genetic sequencing on samples from patients with allergic disease of all sorts, as well as performing functional studies on the same patient samples, which together help point to specific immune pathways that may be fundamentally causing disease. This comprehensive analysis, when performed in larger populations, will help personalize medicine so that patients can be better categorized for targeted care. Furthermore, this type of research and care requires a coordinated and comprehensive interdisciplinary approach, taking advantage of the expertise across the department of pediatrics and at multiple outpatient sites. Dr. Milner is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Autosomal Dominant Hyper IgE Syndrome, Hyper IgE Syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C), and Hereditary Alpha-Tryptasemia. Dr. Milner is board certified in Allergy And Immunology. Dr. Milner is currently accepting new patients.

Dr. Ramsay Fuleihan is the clinical director of the Division of Pediatric Allergy, Immunology and Rheumatology and a professor of pediatrics at Columbia. Throughout his career his main research interest has been the pathogenesis and treatment of primary immunodeficiency diseases. Dr. Fuleihan was formerly chief of the division of allergy and immunology at Sidra Medical and Research Center in Qatar, and Director of Primary Immunodeficiency Clinical Services and the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at Ann & Robert H Lurie Children’s Hospital of Chicago. Dr. Fuleihan earned his medical degree from the American University of Beirut in Lebanon, completed his pediatric residency at Duke University Medical Center, and fellowship in allergy and immunology at the Children’s Hospital-Boston at Harvard Medical School. Dr. Fuleihan is a member of the Board of Directors of the American Board of Allergy and Immunology. He is an active fellow of the American Academy of Allergy Asthma and Immunology, where he served as Chair of the Primary Immunodeficiency Committee; a member of the Clinical Immunology Society, where he served as chair of the CME committee; a member of the European Society for Immunodeficiencies; and a member of the Society for Pediatric Research. He serves on the Medical Advisory Committee of the Immune Deficiency Foundation and on the Board of Directors of Bounce Children’s Foundation. Dr. Fuleihan is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Common Variable Immune Deficiency, Primary Immunodeficiency (PID), Severe Combined Immunodeficiency (SCID), and X-Linked Agammaglobulinemia. Dr. Fuleihan is board certified in Pediatric Allergy And Immunology. Dr. Fuleihan is currently accepting new patients.